top of page
Osimertinib

ANIMAL-FREE OSIMERTINIB OPTIONS ARE AVAILABLE.

Connect with our medical information pharmacists for more details.

 

Why you need to contact us:

Formulations are subject to change, so it's important to consult your healthcare provider or the manufacturer. Our VeganMed pharmacists are here to assist. Please note that our product information is general and not a substitute for professional medical advice. VeganMed does not assess safety or efficacy of medications.

 

Common Brand Name(s): Tagrisso

Indication(s)

  • Adjuvant Treatment of EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)

  • First-line Treatment of EGFR Mutation-Positive Metastatic NSCLC

  • First-line Treatment of EGFR Mutation-Positive Locally Advanced or Metastatic NSCLC

  • Previously Treated EGFR T790M Mutation-Positive Metastatic NSCLC

Drug Class: EGFR inhibitors

Osimertinib

bottom of page